How Will The Biopharmaceutical Fermentation Systems Market Reach $37.73 Billion By 2029 Amid Global Shifts?
Claim 20% Off Global Market Reports With Code ONLINE20 – Insights on Tariff Effects, Global Trade, and Industry Disruptors
How Much Will The Biopharmaceutical Fermentation Systems Market Be Worth By 2029?
The market of biopharmaceutical fermentation systems has shown robust growth in the past few years. The market is estimated to amplify from $24.61 billion in 2024 to $26.6 billion in 2025, escalating at a compound annual growth rate (CAGR) of 8.1%. Factors contributing to this progress during the historic period include rising demand for biologics, supportive regulatory framework, industrial amalgamation, increased funding for research and development, along with the transformation in the healthcare landscape.
Expectations are high for the biopharmaceutical fermentation systems market, with robust growth anticipated over the coming years. The market is projected to reach $37.73 billion by 2029 and experience a compound annual growth rate (CAGR) of 9.1%. This upward trend during the forecast period is primarily due to a variety of factors, including the expansion of the biopharmaceutical pipeline, a shift towards personalized medicine, increased use of continuous bioprocessing, emerging market growth, and advancements in automation and digitalization. Key trends forecasted for this period also comprise a heightened adoption of continuous manufacturing, progress in personalized medicine, growth in the biosimilars market, the application of advanced analytics and AI, and a heightened focus on sustainability and environmental impact.
Get A Free Sample Of The Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15524&type=smp
What Growth-Enabling Forces Are Impacting The Biopharmaceutical Fermentation Systems Market?
The anticipated growth of the biopharmaceutical fermentation systems market is largely driven by the expansion of the biologics pipeline. Biologics are medicinal products derived from living organisms or their constituents, encompassing vaccines, blood and blood components, gene therapies, tissues, and recombinant therapeutic proteins. The upswing in the biologics pipeline can be linked to progressive developments in biotechnology, an amplified understanding of disease mechanisms, and the growing demand for specialized and personalized therapies. Biopharmaceutical fermentation systems play an instrumental role in the production of biologics, allowing the cultivation of genetically engineered cells or microorganisms. This facilitates the large-scale synthesis of elaborate therapeutic proteins, antibodies, and vaccines. For instance, as reported by the National Library of Medicine, a health science library based in the U.S., the Food and Drug Administration (FDA) gave the green light to 55 new drugs in 2023, including 29 new chemical entities (NCEs) and 25 new biological entities (NBEs). This signifies a 50% increase when stacked up against the 37 approvals in the previous year of 2022. Therefore, the escalating biologics pipeline serves as the driving force behind the growth of the biopharmaceutical fermentation systems market.
How Does The Biopharmaceutical Fermentation Systems Market Differ By Segment?
The biopharmaceutical fermentation systems market covered in this report is segmented –
1) By Product: Upstream Products, Downstream Products
2) By Application: Recombinant Proteins, Monoclonal Antibodies, Antibiotics, Probiotics, Other Applications
3) By End-User: Biopharmaceutical Companies, Contract Manufacturing Organizations, Contract Research Organizations, Academic Research Institutes, Food Industry, Other End-Users
Subsegments:
1) By Upstream Products: Fermenters Or Bioreactors, Culture Media, Inoculum Preparation Systems, Gas And Liquid Flow Control Systems, Process Monitoring And Control Systems, Sterilization Systems
2) By Downstream Products: Filtration Systems, Centrifuges, Chromatography Systems, Ultrafiltration And Microfiltration Systems, Concentration And Purification Systems, Packaging And Storage Systems
What New Opportunities Are Emerging From Trends In The Biopharmaceutical Fermentation Systems Market?
Leading firms in the biologics fermentation systems market are focusing on the creation of enhanced fermentation systems, like automated bioreactors, to improve scalability, efficiency, and repeatability. Automated bioreactors are sophisticated bioprocessing units that harness automated control and surveillance technologies to perfect microorganism or cell growth conditions for biopharmaceutical production. For example, in October 2022, Froilabo, a laboratory equipment company based in France, introduced fully automated lab-scale bioreactors. These reactors are devised to deliver versatility and precision across various areas such as academia, research, process development, and production. They provide top-notch aseptic conditions with customizable choices regarding impeller positioning and type, equipped with an innovative magnetic mixer and a non-welded lid.
Which Firms Are Making The Biggest Impact In The Biopharmaceutical Fermentation Systems Market?
Major companies operating in the biopharmaceutical fermentation systems market are F. Hoffmann-La Roche Ltd., Thermo Fisher Scientific Inc., 3M Company, Danaher Corporation, Merck KGaA, Becton Dickinson and Company, GE Healthcare, Agilent Technologies Inc., Lonza Group AG, GEA Group AG, Sartorius Stedim Biotech, Bio-Rad Laboratories Inc., Pall Corporation, Nova Biomedical, Eppendorf AG, Repligen Corporation, ZETA Holding GmbH, New Brunswick Scientific, ABEC Inc., Pierre Guérin Technologies, AntoXa Corporation, Applikon Biotechnology, Cellexus Ltd., Infors HT, BioPharm Process Associates LLC
Access The Complete Report Here:
Which Region Is Leading Innovation In The Biopharmaceutical Fermentation Systems Market?
North America was the largest region in the biopharmaceutical fermentation systems market in 2024. The regions covered in the biopharmaceutical fermentation systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Customize Your Report Here:
https://www.thebusinessresearchcompany.com/customise?id=15524&type=smp
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
